Agios Pharmaceuticals (AGIO) Capital Expenditures Growth (3y) (2015 - 2026)
Agios Pharmaceuticals (AGIO) Capital Expenditures Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.21 Bn | 1.47 Bn | 19.43 Mn | 24.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.45% |
| Dec 31, 2025 | 77.43% |
| Sep 30, 2025 | -31.51% |
| Jun 30, 2025 | 32.25% |
| Mar 31, 2025 | -35.11% |
| Dec 31, 2024 | -28.81% |
| Sep 30, 2024 | -74.77% |
| Jun 30, 2024 | 26.91% |
| Dec 31, 2023 | 27.55% |
| Sep 30, 2023 | -90.69% |
| Jun 30, 2023 | 40.04% |
| Mar 31, 2023 | -58.15% |
| Dec 31, 2022 | -195.31% |
| Sep 30, 2022 | 32.65% |
| Jun 30, 2022 | -61.31% |
| Mar 31, 2022 | 11.22% |
| Dec 31, 2021 | 95.23% |
| Sep 30, 2021 | 49.91% |
| Jun 30, 2021 | -142.55% |
| Mar 31, 2021 | -10.93% |